BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: N. Serhan C, Krishnamoorthy S, Recchiuti A, Chiang N. . CTMC 2011;11:629-47. [DOI: 10.2174/1568026611109060629] [Cited by in Crossref: 188] [Cited by in F6Publishing: 171] [Article Influence: 17.1] [Reference Citation Analysis]
Number Citing Articles
1 Balas L, Durand T. Dihydroxylated E,E,Z-docosatrienes. An overview of their synthesis and biological significance. Progress in Lipid Research 2016;61:1-18. [DOI: 10.1016/j.plipres.2015.10.002] [Cited by in Crossref: 24] [Cited by in F6Publishing: 20] [Article Influence: 4.0] [Reference Citation Analysis]
2 Kasikara C, Doran AC, Cai B, Tabas I. The role of non-resolving inflammation in atherosclerosis. J Clin Invest 2018;128:2713-23. [PMID: 30108191 DOI: 10.1172/JCI97950] [Cited by in Crossref: 92] [Cited by in F6Publishing: 45] [Article Influence: 23.0] [Reference Citation Analysis]
3 Corminboeuf O, Leroy X. FPR2/ALXR agonists and the resolution of inflammation. J Med Chem 2015;58:537-59. [PMID: 25365541 DOI: 10.1021/jm501051x] [Cited by in Crossref: 81] [Cited by in F6Publishing: 78] [Article Influence: 10.1] [Reference Citation Analysis]
4 Im DS. Omega-3 fatty acids in anti-inflammation (pro-resolution) and GPCRs. Prog Lipid Res. 2012;51:232-237. [PMID: 22542696 DOI: 10.1016/j.plipres.2012.02.003] [Cited by in Crossref: 100] [Cited by in F6Publishing: 94] [Article Influence: 10.0] [Reference Citation Analysis]
5 Yao W, Guo A, Han X, Wu S, Chen C, Luo C, Li H, Li S, Hei Z. Aerosol inhalation of a hydrogen-rich solution restored septic renal function. Aging (Albany NY) 2019;11:12097-113. [PMID: 31841441 DOI: 10.18632/aging.102542] [Cited by in Crossref: 6] [Cited by in F6Publishing: 7] [Article Influence: 2.0] [Reference Citation Analysis]
6 Rosenthal MD, Rosenthal CM, Moore FA, Martindale RG. Persistent, Immunosuppression, Inflammation, Catabolism Syndrome and Diaphragmatic Dysfunction. Curr Pulmonol Rep 2017;6:54-7. [DOI: 10.1007/s13665-017-0166-z] [Cited by in Crossref: 10] [Cited by in F6Publishing: 6] [Article Influence: 2.0] [Reference Citation Analysis]
7 van Jaarsveld MTM, Houthuijzen JM, Voest EE. Molecular mechanisms of target recognition by lipid GPCRs: relevance for cancer. Oncogene 2016;35:4021-35. [DOI: 10.1038/onc.2015.467] [Cited by in Crossref: 11] [Cited by in F6Publishing: 12] [Article Influence: 1.6] [Reference Citation Analysis]
8 Dai S, Zhu M, Wu R, Lin D, Huang Z, Ren L, Huang S, Cheng L, Chen Q. Lipoxin A4 Suppresses IL-1β-Induced Cyclooxygenase-2 Expression Through Inhibition of p38 MAPK Activation in Endometriosis. Reprod Sci 2019;26:1640-9. [PMID: 30773096 DOI: 10.1177/1933719119828115] [Cited by in Crossref: 9] [Cited by in F6Publishing: 10] [Article Influence: 3.0] [Reference Citation Analysis]
9 Chávez-Castillo M, Ortega Á, Cudris-Torres L, Duran P, Rojas M, Manzano A, Garrido B, Salazar J, Silva A, Rojas-Gomez DM, De Sanctis JB, Bermúdez V. Specialized Pro-Resolving Lipid Mediators: The Future of Chronic Pain Therapy? Int J Mol Sci 2021;22:10370. [PMID: 34638711 DOI: 10.3390/ijms221910370] [Reference Citation Analysis]
10 Torres P, Cacabelos D, Pairada J, Bauer KC, Boada J, Fontdevila L, Rossi C, Povedano M, Ferrer I, Pamplona R, Finlay BB, Portero-Otín M, Ayala V. Gender-Specific Beneficial Effects of Docosahexaenoic Acid Dietary Supplementation in G93A-SOD1 Amyotrophic Lateral Sclerosis Mice. Neurotherapeutics 2020;17:269-81. [PMID: 31755041 DOI: 10.1007/s13311-019-00808-2] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 5.0] [Reference Citation Analysis]
11 Chen LC, Tseng HM, Kuo ML, Chiu CY, Liao SL, Su KW, Tsai MH, Hua MC, Lai SH, Yao TC, Yeh KW, Wu AH, Huang JL, Huang SK. A composite of exhaled LTB4 , LXA4 , FeNO, and FEV1 as an "asthma classification ratio" characterizes childhood asthma. Allergy 2018;73:627-34. [PMID: 28944471 DOI: 10.1111/all.13318] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 1.0] [Reference Citation Analysis]
12 Quehenberger O, Armando AM, Dennis EA. High sensitivity quantitative lipidomics analysis of fatty acids in biological samples by gas chromatography-mass spectrometry. Biochim Biophys Acta 2011;1811:648-56. [PMID: 21787881 DOI: 10.1016/j.bbalip.2011.07.006] [Cited by in Crossref: 139] [Cited by in F6Publishing: 117] [Article Influence: 12.6] [Reference Citation Analysis]
13 Tateishi N, Kaneda Y, Kakutani S, Kawashima H, Shibata H, Morita I. Dietary supplementation with arachidonic acid increases arachidonic acid content in paw, but does not affect arthritis severity or prostaglandin E2 content in rat adjuvant-induced arthritis model. Lipids Health Dis 2015;14:3. [PMID: 25595700 DOI: 10.1186/1476-511X-14-3] [Cited by in Crossref: 25] [Cited by in F6Publishing: 9] [Article Influence: 3.6] [Reference Citation Analysis]
14 Yan C, Guan F, Shen Y, Tang H, Yuan D, Gao H, Feng X. Bigelovii A Protects against Lipopolysaccharide-Induced Acute Lung Injury by Blocking NF-κB and CCAAT/Enhancer-Binding Protein δ Pathways. Mediators Inflamm. 2016;2016:9201604. [PMID: 27194827 DOI: 10.1155/2016/9201604] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 0.8] [Reference Citation Analysis]
15 Le Faouder P, Baillif V, Spreadbury I, Motta J, Rousset P, Chêne G, Guigné C, Tercé F, Vanner S, Vergnolle N, Bertrand-michel J, Dubourdeau M, Cenac N. LC–MS/MS method for rapid and concomitant quantification of pro-inflammatory and pro-resolving polyunsaturated fatty acid metabolites. Journal of Chromatography B 2013;932:123-33. [DOI: 10.1016/j.jchromb.2013.06.014] [Cited by in Crossref: 115] [Cited by in F6Publishing: 111] [Article Influence: 12.8] [Reference Citation Analysis]
16 Salas-Hernández A, Espinoza-Pérez C, Vivar R, Espitia-Corredor J, Lillo J, Parra-Flores P, Sánchez-Ferrer CF, Peiró C, Díaz-Araya G. Resolvin D1 and E1 promote resolution of inflammation in rat cardiac fibroblast in vitro. Mol Biol Rep 2021;48:57-66. [PMID: 33459958 DOI: 10.1007/s11033-020-06133-8] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 3.0] [Reference Citation Analysis]
17 Fairbairn P, Tsofliou F, Johnson A, Dyall SC. Combining a high DHA multi-nutrient supplement with aerobic exercise: Protocol for a randomised controlled study assessing mobility and cognitive function in older women. Prostaglandins Leukot Essent Fatty Acids 2019;143:21-30. [PMID: 30975379 DOI: 10.1016/j.plefa.2019.04.001] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
18 Ebersole JL, Dawson DR 3rd, Morford LA, Peyyala R, Miller CS, Gonzaléz OA. Periodontal disease immunology: 'double indemnity' in protecting the host. Periodontol 2000 2013;62:163-202. [PMID: 23574466 DOI: 10.1111/prd.12005] [Cited by in Crossref: 85] [Cited by in F6Publishing: 83] [Article Influence: 10.6] [Reference Citation Analysis]
19 Brown I, Cascio MG, Rotondo D, Pertwee RG, Heys SD, Wahle KW. Cannabinoids and omega-3/6 endocannabinoids as cell death and anticancer modulators. Progress in Lipid Research 2013;52:80-109. [DOI: 10.1016/j.plipres.2012.10.001] [Cited by in Crossref: 66] [Cited by in F6Publishing: 50] [Article Influence: 7.3] [Reference Citation Analysis]
20 Greene ER, Huang S, Serhan CN, Panigrahy D. Regulation of inflammation in cancer by eicosanoids. Prostaglandins Other Lipid Mediat. 2011;96:27-36. [PMID: 21864702 DOI: 10.1016/j.prostaglandins.2011.08.004] [Cited by in Crossref: 182] [Cited by in F6Publishing: 179] [Article Influence: 16.5] [Reference Citation Analysis]
21 Fischer CD, Duquette SC, Renaux BS, Feener TD, Morck DW, Hollenberg MD, Lucas MJ, Buret AG. Tulathromycin exerts proresolving effects in bovine neutrophils by inhibiting phospholipases and altering leukotriene B4, prostaglandin E2, and lipoxin A4 production. Antimicrob Agents Chemother 2014;58:4298-307. [PMID: 24820086 DOI: 10.1128/AAC.02813-14] [Cited by in Crossref: 10] [Cited by in F6Publishing: 2] [Article Influence: 1.3] [Reference Citation Analysis]
22 Kumar N, Gupta G, Anilkumar K, Fatima N, Karnati R, Reddy GV, Giri PV, Reddanna P. 15-Lipoxygenase metabolites of α-linolenic acid, [13-(S)-HPOTrE and 13-(S)-HOTrE], mediate anti-inflammatory effects by inactivating NLRP3 inflammasome. Sci Rep 2016;6:31649. [PMID: 27535180 DOI: 10.1038/srep31649] [Cited by in Crossref: 46] [Cited by in F6Publishing: 46] [Article Influence: 7.7] [Reference Citation Analysis]
23 Çalışkan B, Banoglu E. Overview of recent drug discovery approaches for new generation leukotriene A 4 hydrolase inhibitors. Expert Opinion on Drug Discovery 2012;8:49-63. [DOI: 10.1517/17460441.2013.735228] [Cited by in Crossref: 26] [Cited by in F6Publishing: 24] [Article Influence: 2.6] [Reference Citation Analysis]
24 Biringer RG. A review of non-prostanoid, eicosanoid receptors: expression, characterization, regulation, and mechanism of action. J Cell Commun Signal 2021. [PMID: 34173964 DOI: 10.1007/s12079-021-00630-6] [Reference Citation Analysis]
25 Arita M. Mediator lipidomics in acute inflammation and resolution. J Biochem. 2012;152:313-319. [PMID: 22923733 DOI: 10.1093/jb/mvs092] [Cited by in Crossref: 95] [Cited by in F6Publishing: 84] [Article Influence: 9.5] [Reference Citation Analysis]
26 Jaén RI, Fernández-Velasco M, Terrón V, Sánchez-García S, Zaragoza C, Canales-Bueno N, Val-Blasco A, Vallejo-Cremades MT, Boscá L, Prieto P. BML-111 treatment prevents cardiac apoptosis and oxidative stress in a mouse model of autoimmune myocarditis. FASEB J 2020;34:10531-46. [PMID: 32543747 DOI: 10.1096/fj.202000611R] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
27 Cash JL, Norling LV, Perretti M. Resolution of inflammation: targeting GPCRs that interact with lipids and peptides. Drug Discov Today 2014;19:1186-92. [PMID: 24993159 DOI: 10.1016/j.drudis.2014.06.023] [Cited by in Crossref: 36] [Cited by in F6Publishing: 36] [Article Influence: 4.5] [Reference Citation Analysis]
28 Tucker SC, Honn KV. Emerging targets in lipid-based therapy. Biochem Pharmacol 2013;85:673-88. [PMID: 23261527 DOI: 10.1016/j.bcp.2012.11.028] [Cited by in Crossref: 16] [Cited by in F6Publishing: 12] [Article Influence: 1.6] [Reference Citation Analysis]
29 Ulu A, Sahoo PK, Yuil-Valdes AG, Mukherjee M, Van Ormer M, Muthuraj PG, Thompson M, Anderson Berry A, Hanson CK, Natarajan SK, Nordgren TM. Omega-3 Fatty Acid-Derived Resolvin D2 Regulates Human Placental Vascular Smooth Muscle and Extravillous Trophoblast Activities. Int J Mol Sci 2019;20:E4402. [PMID: 31500240 DOI: 10.3390/ijms20184402] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 2.0] [Reference Citation Analysis]
30 Pearce EL, Pearce EJ. Metabolic pathways in immune cell activation and quiescence. Immunity. 2013;38:633-643. [PMID: 23601682 DOI: 10.1016/j.immuni.2013.04.005] [Cited by in Crossref: 770] [Cited by in F6Publishing: 749] [Article Influence: 85.6] [Reference Citation Analysis]
31 Merched AJ, Chan L. Nutrigenetics and nutrigenomics of atherosclerosis. Curr Atheroscler Rep 2013;15:328. [PMID: 23605288 DOI: 10.1007/s11883-013-0328-6] [Cited by in Crossref: 15] [Cited by in F6Publishing: 12] [Article Influence: 1.7] [Reference Citation Analysis]
32 Barden AE, Moghaddami M, Mas E, Phillips M, Cleland LG, Mori TA. Specialised pro-resolving mediators of inflammation in inflammatory arthritis. Prostaglandins, Leukotrienes and Essential Fatty Acids 2016;107:24-9. [DOI: 10.1016/j.plefa.2016.03.004] [Cited by in Crossref: 71] [Cited by in F6Publishing: 72] [Article Influence: 11.8] [Reference Citation Analysis]
33 Nordgren TM, Heires AJ, Wyatt TA, Poole JA, LeVan TD, Cerutis DR, Romberger DJ. Maresin-1 reduces the pro-inflammatory response of bronchial epithelial cells to organic dust. Respir Res 2013;14:51. [PMID: 23663457 DOI: 10.1186/1465-9921-14-51] [Cited by in Crossref: 40] [Cited by in F6Publishing: 38] [Article Influence: 4.4] [Reference Citation Analysis]
34 Jutley G, Raza K, Buckley CD. New pathogenic insights into rheumatoid arthritis. Curr Opin Rheumatol 2015;27:249-55. [PMID: 25775189 DOI: 10.1097/BOR.0000000000000174] [Cited by in Crossref: 23] [Cited by in F6Publishing: 15] [Article Influence: 3.3] [Reference Citation Analysis]
35 Rosenthal MD, Kamel AY, Rosenthal CM, Brakenridge S, Croft CA, Moore FA. Chronic Critical Illness: Application of What We Know. Nutr Clin Pract 2018;33:39-45. [PMID: 29323761 DOI: 10.1002/ncp.10024] [Cited by in Crossref: 13] [Cited by in F6Publishing: 13] [Article Influence: 3.3] [Reference Citation Analysis]
36 Serhan CN. Discovery of specialized pro-resolving mediators marks the dawn of resolution physiology and pharmacology. Mol Aspects Med 2017;58:1-11. [PMID: 28263773 DOI: 10.1016/j.mam.2017.03.001] [Cited by in Crossref: 103] [Cited by in F6Publishing: 93] [Article Influence: 20.6] [Reference Citation Analysis]
37 Elder CT, Filiberto AC, Su G, Ladd Z, Leroy V, Pruitt EY, Lu G, Jiang Z, Sharma AK, Upchurch GR Jr. Maresin 1 activates LGR6 signaling to inhibit smooth muscle cell activation and attenuate murine abdominal aortic aneurysm formation. FASEB J 2021;35:e21780. [PMID: 34320253 DOI: 10.1096/fj.202100484R] [Reference Citation Analysis]
38 Lu S, Wu X, Xin S, Zhang J, Lin H, Miao Y, Li Y. Knockdown of circ_0001679 alleviates lipopolysaccharide-induced MLE-12 lung cell injury by regulating the miR-338-3p/ mitogen-activated protein kinase 1 axis. Bioengineered 2022;13:5803-17. [PMID: 35264058 DOI: 10.1080/21655979.2022.2034564] [Reference Citation Analysis]
39 Wei J, Gronert K. Eicosanoid and Specialized Proresolving Mediator Regulation of Lymphoid Cells. Trends Biochem Sci 2019;44:214-25. [PMID: 30477730 DOI: 10.1016/j.tibs.2018.10.007] [Cited by in Crossref: 12] [Cited by in F6Publishing: 13] [Article Influence: 3.0] [Reference Citation Analysis]
40 Layé S, Nadjar A, Joffre C, Bazinet RP. Anti-Inflammatory Effects of Omega-3 Fatty Acids in the Brain: Physiological Mechanisms and Relevance to Pharmacology. Pharmacol Rev 2018;70:12-38. [PMID: 29217656 DOI: 10.1124/pr.117.014092] [Cited by in Crossref: 157] [Cited by in F6Publishing: 129] [Article Influence: 31.4] [Reference Citation Analysis]
41 He X, Hu JL, Li J, Zhao L, Zhang Y, Zeng YJ, Dai SS, He FT. A feedback loop in PPARγ-adenosine A2A receptor signaling inhibits inflammation and attenuates lung damages in a mouse model of LPS-induced acute lung injury. Cell Signal 2013;25:1913-23. [PMID: 23712033 DOI: 10.1016/j.cellsig.2013.05.024] [Cited by in Crossref: 26] [Cited by in F6Publishing: 24] [Article Influence: 2.9] [Reference Citation Analysis]
42 Kurgan S, Kantarci A. Molecular basis for immunohistochemical and inflammatory changes during progression of gingivitis to periodontitis. Periodontol 2000 2018;76:51-67. [DOI: 10.1111/prd.12146] [Cited by in Crossref: 28] [Cited by in F6Publishing: 24] [Article Influence: 5.6] [Reference Citation Analysis]
43 Martindale RG, Warren MM, McClave SA. Does the use of specialized proresolving molecules in critical care offer a more focused approach to controlling inflammation than that of fish oils? Curr Opin Clin Nutr Metab Care 2016;19:151-4. [PMID: 26828585 DOI: 10.1097/MCO.0000000000000250] [Cited by in Crossref: 13] [Cited by in F6Publishing: 6] [Article Influence: 2.2] [Reference Citation Analysis]
44 Kim N, Ramon S, Thatcher TH, Woeller CF, Sime PJ, Phipps RP. Specialized proresolving mediators (SPMs) inhibit human B-cell IgE production. Eur J Immunol 2016;46:81-91. [PMID: 26474728 DOI: 10.1002/eji.201545673] [Cited by in Crossref: 32] [Cited by in F6Publishing: 33] [Article Influence: 4.6] [Reference Citation Analysis]
45 Buechler C, Pohl R, Aslanidis C. Pro-Resolving Molecules-New Approaches to Treat Sepsis? Int J Mol Sci 2017;18:E476. [PMID: 28241480 DOI: 10.3390/ijms18030476] [Cited by in Crossref: 14] [Cited by in F6Publishing: 16] [Article Influence: 2.8] [Reference Citation Analysis]
46 McEvoy CM, Clotet-Freixas S, Tokar T, Pastrello C, Reid S, Batruch I, RaoPeters AAE, Kaths JM, Urbanellis P, Farkona S, Van JAD, Urquhart BL, John R, Jurisica I, Robinson LA, Selzner M, Konvalinka A. Normothermic Ex-vivo Kidney Perfusion in a Porcine Auto-Transplantation Model Preserves the Expression of Key Mitochondrial Proteins: An Unbiased Proteomics Analysis. Mol Cell Proteomics 2021;20:100101. [PMID: 34033948 DOI: 10.1016/j.mcpro.2021.100101] [Reference Citation Analysis]
47 Thornton JM, Yin K. Role of Specialized Pro-Resolving Mediators in Modifying Host Defense and Decreasing Bacterial Virulence. Molecules 2021;26:6970. [PMID: 34834062 DOI: 10.3390/molecules26226970] [Reference Citation Analysis]
48 Lindberg R, Lindqvist M, Trupp M, Vinnars MT, Nording ML. Polyunsaturated Fatty Acids and Their Metabolites in Hyperemesis Gravidarum. Nutrients 2020;12:E3384. [PMID: 33158081 DOI: 10.3390/nu12113384] [Reference Citation Analysis]
49 Vergelli C, Schepetkin IA, Ciciani G, Cilibrizzi A, Crocetti L, Giovannoni MP, Guerrini G, Iacovone A, Kirpotina LN, Ye RD, Quinn MT. Synthesis of Five- and Six-Membered N-Phenylacetamido Substituted Heterocycles as Formyl Peptide Receptor Agonists. Drug Dev Res 2017;78:49-62. [PMID: 27859446 DOI: 10.1002/ddr.21370] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 0.8] [Reference Citation Analysis]
50 Tam VC. Lipidomic profiling of bioactive lipids by mass spectrometry during microbial infections. Semin Immunol 2013;25:240-8. [PMID: 24084369 DOI: 10.1016/j.smim.2013.08.006] [Cited by in Crossref: 64] [Cited by in F6Publishing: 61] [Article Influence: 7.1] [Reference Citation Analysis]
51 Kang S, Park SJ, Lee AY, Huang J, Chung HY, Im DS. Ginsenoside Rg3 promotes inflammation resolution through M2 macrophage polarization. J Ginseng Res 2018;42:68-74. [PMID: 29348724 DOI: 10.1016/j.jgr.2016.12.012] [Cited by in Crossref: 23] [Cited by in F6Publishing: 18] [Article Influence: 4.6] [Reference Citation Analysis]
52 Xu Z, Zhao F, Xiang H, Wang N, Ye D, Huang Y. Lipoxin A4: The double-edge sword in mice pregnancy. Am J Reprod Immunol 2014;72:57-64. [PMID: 24712656 DOI: 10.1111/aji.12242] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 0.5] [Reference Citation Analysis]
53 Liu Y, Zhou D, Long FW, Chen KL, Yang HW, Lv ZY, Zhou B, Peng ZH, Sun XF, Li Y. Resolvin D1 protects against inflammation in experimental acute pancreatitis and associated lung injury. Am J Physiol Gastrointest Liver Physiol. 2016;310:G303-G309. [PMID: 26702138 DOI: 10.1152/ajpgi.00355.2014] [Cited by in Crossref: 16] [Cited by in F6Publishing: 20] [Article Influence: 2.3] [Reference Citation Analysis]
54 Rosenthal MD, Kamel AY, Brown MP, Young AC, Patel JJ, Moore FA. Nutrition for Chronic Critical Illness and Persistent Inflammatory, Immunosuppressed, Catabolic Syndrome. In: Mahmoudi M, Rezaei N, editors. Nutrition and Immunity. Cham: Springer International Publishing; 2019. pp. 407-13. [DOI: 10.1007/978-3-030-16073-9_20] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
55 Morita M, Kuba K, Ichikawa A, Nakayama M, Katahira J, Iwamoto R, Watanebe T, Sakabe S, Daidoji T, Nakamura S, Kadowaki A, Ohto T, Nakanishi H, Taguchi R, Nakaya T, Murakami M, Yoneda Y, Arai H, Kawaoka Y, Penninger JM, Arita M, Imai Y. The lipid mediator protectin D1 inhibits influenza virus replication and improves severe influenza. Cell 2013;153:112-25. [PMID: 23477864 DOI: 10.1016/j.cell.2013.02.027] [Cited by in Crossref: 270] [Cited by in F6Publishing: 260] [Article Influence: 30.0] [Reference Citation Analysis]
56 Jarosz AC, Badawi A. Metabolites of prostaglandin synthases as potential biomarkers of Lyme disease severity and symptom resolution. Inflamm Res 2019;68:7-17. [PMID: 30121835 DOI: 10.1007/s00011-018-1180-5] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
57 Chavez-Dominguez R, Perez-Medina M, Aguilar-Cazares D, Galicia-Velasco M, Meneses-Flores M, Islas-Vazquez L, Camarena A, Lopez-Gonzalez JS. Old and New Players of Inflammation and Their Relationship With Cancer Development. Front Oncol 2021;11:722999. [PMID: 34881173 DOI: 10.3389/fonc.2021.722999] [Reference Citation Analysis]
58 Sharma S, Sundararajan A, Suryawanshi A, Kumar N, Veiga-Parga T, Kuchroo VK, Thomas PG, Sangster MY, Rouse BT. T cell immunoglobulin and mucin protein-3 (Tim-3)/Galectin-9 interaction regulates influenza A virus-specific humoral and CD8 T-cell responses. Proc Natl Acad Sci U S A. 2011;108:19001-19006. [PMID: 22052881 DOI: 10.1073/pnas.1107087108] [Cited by in Crossref: 64] [Cited by in F6Publishing: 63] [Article Influence: 5.8] [Reference Citation Analysis]
59 Singh A, Rahman T, Bartiss R, Arabshahi A, Prasain J, Barnes S, Musteata FM, Sellati TJ. Lipoxin A4, a 5-lipoxygenase pathway metabolite, modulates immune response during acute respiratory tularemia. J Leukoc Biol 2017;101:531-42. [PMID: 27630217 DOI: 10.1189/jlb.4A0815-365RR] [Cited by in Crossref: 7] [Cited by in F6Publishing: 4] [Article Influence: 1.2] [Reference Citation Analysis]
60 Zahoor I, Giri S. Specialized Pro-Resolving Lipid Mediators: Emerging Therapeutic Candidates for Multiple Sclerosis. Clin Rev Allergy Immunol 2021;60:147-63. [PMID: 32495237 DOI: 10.1007/s12016-020-08796-4] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
61 Serhan CN, Chiang N, Dalli J. New pro-resolving n-3 mediators bridge resolution of infectious inflammation to tissue regeneration. Mol Aspects Med 2018;64:1-17. [PMID: 28802833 DOI: 10.1016/j.mam.2017.08.002] [Cited by in Crossref: 92] [Cited by in F6Publishing: 106] [Article Influence: 18.4] [Reference Citation Analysis]
62 Edin ML, Zeldin DC. Commercial scale production of RvD4 opens the resolving door to new research. J Leukoc Biol 2018. [PMID: 29603390 DOI: 10.1002/JLB.3CE0118-032R] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
63 Lannan KL, Spinelli SL, Blumberg N, Phipps RP. Maresin 1 induces a novel pro-resolving phenotype in human platelets. J Thromb Haemost 2017;15:802-13. [PMID: 28079976 DOI: 10.1111/jth.13620] [Cited by in Crossref: 30] [Cited by in F6Publishing: 30] [Article Influence: 6.0] [Reference Citation Analysis]
64 Ortega-Gómez A, Perretti M, Soehnlein O. Resolution of inflammation: an integrated view. EMBO Mol Med 2013;5:661-74. [PMID: 23592557 DOI: 10.1002/emmm.201202382] [Cited by in Crossref: 404] [Cited by in F6Publishing: 376] [Article Influence: 44.9] [Reference Citation Analysis]
65 Serhan CN, Dalli J, Karamnov S, Choi A, Park CK, Xu ZZ, Ji RR, Zhu M, Petasis NA. Macrophage proresolving mediator maresin 1 stimulates tissue regeneration and controls pain. FASEB J 2012;26:1755-65. [PMID: 22253477 DOI: 10.1096/fj.11-201442] [Cited by in Crossref: 276] [Cited by in F6Publishing: 266] [Article Influence: 27.6] [Reference Citation Analysis]
66 Perretti M, Di Filippo C, D'Amico M, Dalli J. Characterizing the anti-inflammatory and tissue protective actions of a novel Annexin A1 peptide. PLoS One 2017;12:e0175786. [PMID: 28407017 DOI: 10.1371/journal.pone.0175786] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 1.6] [Reference Citation Analysis]
67 Fiala M, Weitzman R. 1α,25-Dihydroxyvitamin D3 and Resolvins Improve Immunity to Amyloid-β in Patients with Alzheimer’s Disease. Diet and Nutrition in Dementia and Cognitive Decline. Elsevier; 2015. pp. 701-8. [DOI: 10.1016/b978-0-12-407824-6.00064-1] [Cited by in Crossref: 1] [Article Influence: 0.1] [Reference Citation Analysis]
68 Cai B, Thorp EB, Doran AC, Sansbury BE, Daemen MJ, Dorweiler B, Spite M, Fredman G, Tabas I. MerTK receptor cleavage promotes plaque necrosis and defective resolution in atherosclerosis. J Clin Invest 2017;127:564-8. [PMID: 28067670 DOI: 10.1172/JCI90520] [Cited by in Crossref: 82] [Cited by in F6Publishing: 61] [Article Influence: 16.4] [Reference Citation Analysis]
69 Barnig C, Bezema T, Calder PC, Charloux A, Frossard N, Garssen J, Haworth O, Dilevskaya K, Levi-Schaffer F, Lonsdorfer E, Wauben M, Kraneveld AD, Te Velde AA. Activation of Resolution Pathways to Prevent and Fight Chronic Inflammation: Lessons From Asthma and Inflammatory Bowel Disease. Front Immunol 2019;10:1699. [PMID: 31396220 DOI: 10.3389/fimmu.2019.01699] [Cited by in Crossref: 21] [Cited by in F6Publishing: 21] [Article Influence: 7.0] [Reference Citation Analysis]
70 Mullane K. The increasing challenge of discovering asthma drugs. Biochem Pharmacol 2011;82:586-99. [PMID: 21745459 DOI: 10.1016/j.bcp.2011.06.033] [Cited by in Crossref: 35] [Cited by in F6Publishing: 32] [Article Influence: 3.2] [Reference Citation Analysis]
71 Kwon Y. Immuno-Resolving Ability of Resolvins, Protectins, and Maresins Derived from Omega-3 Fatty Acids in Metabolic Syndrome. Mol Nutr Food Res 2020;64:e1900824. [PMID: 31797565 DOI: 10.1002/mnfr.201900824] [Cited by in Crossref: 17] [Cited by in F6Publishing: 15] [Article Influence: 5.7] [Reference Citation Analysis]
72 Chen J, Zeng T, Bi Y, Zhong Z, Xie K, Zhao X. Docosahexaenoic acid (DHA) attenuated paraquat induced lung damage in mice. Inhalation Toxicology 2013;25:9-16. [DOI: 10.3109/08958378.2012.750405] [Cited by in Crossref: 12] [Cited by in F6Publishing: 13] [Article Influence: 1.3] [Reference Citation Analysis]
73 Elliott E, Hanson CK, Anderson-Berry AL, Nordgren TM. The role of specialized pro-resolving mediators in maternal-fetal health. Prostaglandins Leukot Essent Fatty Acids 2017;126:98-104. [PMID: 29031403 DOI: 10.1016/j.plefa.2017.09.017] [Cited by in Crossref: 11] [Cited by in F6Publishing: 10] [Article Influence: 2.2] [Reference Citation Analysis]
74 Caligiuri SP, Love K, Winter T, Gauthier J, Taylor CG, Blydt-Hansen T, Zahradka P, Aukema HM. Dietary linoleic acid and α-linolenic acid differentially affect renal oxylipins and phospholipid fatty acids in diet-induced obese rats. J Nutr 2013;143:1421-31. [PMID: 23902961 DOI: 10.3945/jn.113.177360] [Cited by in Crossref: 40] [Cited by in F6Publishing: 36] [Article Influence: 4.4] [Reference Citation Analysis]
75 Schafer P. Apremilast mechanism of action and application to psoriasis and psoriatic arthritis. Biochem Pharmacol. 2012;83:1583-1590. [PMID: 22257911 DOI: 10.1016/j.bcp.2012.01.001] [Cited by in Crossref: 231] [Cited by in F6Publishing: 186] [Article Influence: 23.1] [Reference Citation Analysis]
76 Polinski KJ, Bemis EA, Yang F, Crume T, Demoruelle MK, Feser M, Seifert J, O'Dell JR, Mikuls TR, Weisman MH, Gregersen PK, Keating RM, Buckner J, Reisdorph N, Deane KD, Clare-Salzler M, Holers VM, Norris JM. Association of Lipid Mediators With Development of Future Incident Inflammatory Arthritis in an Anti-Citrullinated Protein Antibody-Positive Population. Arthritis Rheumatol 2021;73:955-62. [PMID: 33381911 DOI: 10.1002/art.41631] [Reference Citation Analysis]
77 Doğan ESK, Doğan B, Fentoğlu Ö, Kırzıoğlu FY. The role of serum lipoxin A4 levels in the association between periodontal disease and metabolic syndrome. J Periodontal Implant Sci 2019;49:105-13. [PMID: 31098331 DOI: 10.5051/jpis.2019.49.2.105] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 2.0] [Reference Citation Analysis]
78 Moosheer SM, Waldschütz W, Itariu BK, Brath H, Stulnig TM. A protein-enriched low glycemic index diet with omega-3 polyunsaturated fatty acid supplementation exerts beneficial effects on metabolic control in type 2 diabetes. Prim Care Diabetes 2014;8:308-14. [PMID: 24656509 DOI: 10.1016/j.pcd.2014.02.004] [Cited by in Crossref: 16] [Cited by in F6Publishing: 15] [Article Influence: 2.0] [Reference Citation Analysis]
79 Alashmali SM, Hopperton KE, Bazinet RP. Lowering dietary n-6 polyunsaturated fatty acids: interaction with brain arachidonic and docosahexaenoic acids. Curr Opin Lipidol 2016;27:54-66. [PMID: 26709472 DOI: 10.1097/MOL.0000000000000255] [Cited by in Crossref: 14] [Cited by in F6Publishing: 8] [Article Influence: 2.3] [Reference Citation Analysis]
80 Farooqui AA, Farooqui T. Prevention of Oxidative Stress by Omega-3 Fatty Acids in the Brain. In: Hegde MV, Zanwar AA, Adekar SP, editors. Omega-3 Fatty Acids. Cham: Springer International Publishing; 2016. pp. 239-49. [DOI: 10.1007/978-3-319-40458-5_19] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
81 Michael-titus AT, Priestley JV. Omega-3 fatty acids and traumatic neurological injury: from neuroprotection to neuroplasticity? Trends in Neurosciences 2014;37:30-8. [DOI: 10.1016/j.tins.2013.10.005] [Cited by in Crossref: 60] [Cited by in F6Publishing: 46] [Article Influence: 7.5] [Reference Citation Analysis]
82 Quiros M, Nusrat A. Saving Problematic Mucosae: SPMs in Intestinal Mucosal Inflammation and Repair. Trends Mol Med 2019;25:124-35. [PMID: 30642681 DOI: 10.1016/j.molmed.2018.12.004] [Cited by in Crossref: 11] [Cited by in F6Publishing: 11] [Article Influence: 3.7] [Reference Citation Analysis]
83 Keenan RT, Nowatzky J, Pillinger MH. Etiology and Pathogenesis of Hyperuricemia and Gout. Kelley's Textbook of Rheumatology. Elsevier; 2013. pp. 1533-1553.e5. [DOI: 10.1016/b978-1-4377-1738-9.00094-3] [Cited by in Crossref: 5] [Article Influence: 0.6] [Reference Citation Analysis]
84 Sulciner ML, Gartung A, Gilligan MM, Serhan CN, Panigrahy D. Targeting lipid mediators in cancer biology. Cancer Metastasis Rev 2018;37:557-72. [PMID: 30136088 DOI: 10.1007/s10555-018-9754-9] [Cited by in Crossref: 23] [Cited by in F6Publishing: 26] [Article Influence: 7.7] [Reference Citation Analysis]
85 Daak AA, Lopez-Toledano MA, Heeney MM. Biochemical and therapeutic effects of Omega-3 fatty acids in sickle cell disease. Complement Ther Med 2020;52:102482. [PMID: 32951732 DOI: 10.1016/j.ctim.2020.102482] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 1.5] [Reference Citation Analysis]
86 El-Ansary A, Al-Ayadhi L. Relative abundance of short chain and polyunsaturated fatty acids in propionic acid-induced autistic features in rat pups as potential markers in autism. Lipids Health Dis 2014;13:140. [PMID: 25175350 DOI: 10.1186/1476-511X-13-140] [Cited by in Crossref: 25] [Cited by in F6Publishing: 7] [Article Influence: 3.1] [Reference Citation Analysis]
87 Caligiuri SP, Blydt-hansen T, Love K, Grégoire M, Taylor CG, Zahradka P, Aukema HM. Evidence for the use of glomerulomegaly as a surrogate marker of glomerular damage and for alpha-linolenic acid-rich oils in the treatment of early obesity-related glomerulopathy in a diet-induced rodent model of obesity. Appl Physiol Nutr Metab 2014;39:951-9. [DOI: 10.1139/apnm-2013-0476] [Cited by in Crossref: 9] [Cited by in F6Publishing: 7] [Article Influence: 1.1] [Reference Citation Analysis]
88 Stama ML, Lacivita E, Kirpotina LN, Niso M, Perrone R, Schepetkin IA, Quinn MT, Leopoldo M. Functional N-Formyl Peptide Receptor 2 (FPR2) Antagonists Based on the Ureidopropanamide Scaffold Have Potential To Protect Against Inflammation-Associated Oxidative Stress. ChemMedChem 2017;12:1839-47. [PMID: 28922577 DOI: 10.1002/cmdc.201700429] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 1.0] [Reference Citation Analysis]
89 Barden A, Shinde S, Tsai I, Croft K, Beilin L, Puddey I, Mori T. Effect of weight loss on neutrophil resolvins in the metabolic syndrome. Prostaglandins, Leukotrienes and Essential Fatty Acids 2019;148:25-9. [DOI: 10.1016/j.plefa.2019.07.001] [Cited by in Crossref: 8] [Cited by in F6Publishing: 9] [Article Influence: 2.7] [Reference Citation Analysis]
90 Giacobbe J, Benoiton B, Zunszain P, Pariante CM, Borsini A. The Anti-Inflammatory Role of Omega-3 Polyunsaturated Fatty Acids Metabolites in Pre-Clinical Models of Psychiatric, Neurodegenerative, and Neurological Disorders. Front Psychiatry 2020;11:122. [PMID: 32180741 DOI: 10.3389/fpsyt.2020.00122] [Cited by in Crossref: 20] [Cited by in F6Publishing: 15] [Article Influence: 10.0] [Reference Citation Analysis]
91 Zak DE, Tam VC, Aderem A. Systems-level analysis of innate immunity. Annu Rev Immunol 2014;32:547-77. [PMID: 24655298 DOI: 10.1146/annurev-immunol-032713-120254] [Cited by in Crossref: 40] [Cited by in F6Publishing: 36] [Article Influence: 5.0] [Reference Citation Analysis]
92 Biringer RG. The Role of Eicosanoids in Alzheimer's Disease. Int J Environ Res Public Health 2019;16:E2560. [PMID: 31323750 DOI: 10.3390/ijerph16142560] [Cited by in Crossref: 9] [Cited by in F6Publishing: 10] [Article Influence: 3.0] [Reference Citation Analysis]
93 Körner A, Schlegel M, Theurer J, Frohnmeyer H, Adolph M, Heijink M, Giera M, Rosenberger P, Mirakaj V. Resolution of inflammation and sepsis survival are improved by dietary Ω-3 fatty acids. Cell Death Differ 2018;25:421-31. [PMID: 29053142 DOI: 10.1038/cdd.2017.177] [Cited by in Crossref: 30] [Cited by in F6Publishing: 31] [Article Influence: 6.0] [Reference Citation Analysis]
94 Owens CD, Gasper WJ, Rahman AS, Conte MS. Vein graft failure. J Vasc Surg 2015;61:203-16. [PMID: 24095042 DOI: 10.1016/j.jvs.2013.08.019] [Cited by in Crossref: 74] [Cited by in F6Publishing: 69] [Article Influence: 8.2] [Reference Citation Analysis]
95 Abshagen K, Hartmann A, Grüner L, Liebig M, Vollmar B. Limited potential of resolvin D1 in treatment of cholestatic liver fibrosis. Hepatobiliary Surg Nutr 2020;9:587-96. [PMID: 33163509 DOI: 10.21037/hbsn.2019.08.07] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
96 Crocetti L, Vergelli C, Guerrini G, Cantini N, Kirpotina LN, Schepetkin IA, Quinn MT, Parisio C, Di Cesare Mannelli L, Ghelardini C, Giovannoni MP. Novel formyl peptide receptor (FPR) agonists with pyridinone and pyrimidindione scaffolds that are potentially useful for the treatment of rheumatoid arthritis. Bioorg Chem 2020;100:103880. [PMID: 32388428 DOI: 10.1016/j.bioorg.2020.103880] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 2.5] [Reference Citation Analysis]
97 Ahmmed MK, Ahmmed F, Tian HS, Carne A, Bekhit AE. Marine omega-3 (n-3) phospholipids: A comprehensive review of their properties, sources, bioavailability, and relation to brain health. Compr Rev Food Sci Food Saf 2020;19:64-123. [PMID: 33319514 DOI: 10.1111/1541-4337.12510] [Cited by in Crossref: 47] [Cited by in F6Publishing: 29] [Article Influence: 15.7] [Reference Citation Analysis]
98 Bratton DL, Henson PM. Neutrophil clearance: when the party is over, clean-up begins. Trends Immunol. 2011;32:350-357. [PMID: 21782511 DOI: 10.1016/j.it.2011.04.009] [Cited by in Crossref: 188] [Cited by in F6Publishing: 170] [Article Influence: 17.1] [Reference Citation Analysis]
99 Famenini S, Rigali EA, Olivera-Perez HM, Dang J, Chang MT, Halder R, Rao RV, Pellegrini M, Porter V, Bredesen D, Fiala M. Increased intermediate M1-M2 macrophage polarization and improved cognition in mild cognitive impairment patients on ω-3 supplementation. FASEB J 2017;31:148-60. [PMID: 27677546 DOI: 10.1096/fj.201600677RR] [Cited by in Crossref: 42] [Cited by in F6Publishing: 37] [Article Influence: 7.0] [Reference Citation Analysis]
100 Pascoal LB, Palma BB, Chaim FHM, de Castro MM, Damázio TA, Franceschini APMF, Milanski M, Velloso LA, Leal RF. New translational and experimental insights into the role of pro-resolving lipid mediators in inflammatory bowel disease. World J Exp Med 2022; 12(1): 1-15 [DOI: 10.5493/wjem.v12.i1.1] [Reference Citation Analysis]
101 Trojan E, Tylek K, Leśkiewicz M, Lasoń W, Brandenburg LO, Leopoldo M, Lacivita E, Basta-Kaim A. The N-Formyl Peptide Receptor 2 (FPR2) Agonist MR-39 Exhibits Anti-Inflammatory Activity in LPS-Stimulated Organotypic Hippocampal Cultures. Cells 2021;10:1524. [PMID: 34204273 DOI: 10.3390/cells10061524] [Reference Citation Analysis]
102 Fenton JI, Gurzell EA, Davidson EA, Harris WS. Red blood cell PUFAs reflect the phospholipid PUFA composition of major organs. Prostaglandins, Leukotrienes and Essential Fatty Acids 2016;112:12-23. [DOI: 10.1016/j.plefa.2016.06.004] [Cited by in Crossref: 39] [Cited by in F6Publishing: 37] [Article Influence: 6.5] [Reference Citation Analysis]
103 Mozaffarian D, Kabagambe EK, Johnson CO, Lemaitre RN, Manichaikul A, Sun Q, Foy M, Wang L, Wiener H, Irvin MR, Rich SS, Wu H, Jensen MK, Chasman DI, Chu AY, Fornage M, Steffen L, King IB, McKnight B, Psaty BM, Djoussé L, Chen IY, Wu JH, Siscovick DS, Ridker PM, Tsai MY, Rimm EB, Hu FB, Arnett DK. Genetic loci associated with circulating phospholipid trans fatty acids: a meta-analysis of genome-wide association studies from the CHARGE Consortium. Am J Clin Nutr 2015;101:398-406. [PMID: 25646338 DOI: 10.3945/ajcn.114.094557] [Cited by in Crossref: 32] [Cited by in F6Publishing: 29] [Article Influence: 4.0] [Reference Citation Analysis]
104 Barnig C, Frossard N, Levy BD. Towards targeting resolution pathways of airway inflammation in asthma. Pharmacol Ther 2018;186:98-113. [PMID: 29352860 DOI: 10.1016/j.pharmthera.2018.01.004] [Cited by in Crossref: 37] [Cited by in F6Publishing: 37] [Article Influence: 9.3] [Reference Citation Analysis]
105 Hiram R, Rizcallah E, Sirois C, Sirois M, Morin C, Fortin S, Rousseau E. Resolvin D1 reverses reactivity and Ca2+ sensitivity induced by ET-1, TNF-α, and IL-6 in the human pulmonary artery. Am J Physiol Heart Circ Physiol 2014;307:H1547-58. [PMID: 25281570 DOI: 10.1152/ajpheart.00452.2014] [Cited by in Crossref: 19] [Cited by in F6Publishing: 18] [Article Influence: 2.4] [Reference Citation Analysis]
106 Sharma VK, Savitha S, Vinod KV, Rajappa M, Subramanian SK, Rajendran R. Assessment of autonomic functions and its association with telomerase level, oxidative stress and inflammation in complete glycemic spectrum– an exploratory study. Diabetes & Metabolic Syndrome: Clinical Research & Reviews 2019;13:1193-9. [DOI: 10.1016/j.dsx.2019.01.011] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
107 Shamoon L, Espitia-Corredor JA, Dongil P, Menéndez-Ribes M, Romero A, Valencia I, Díaz-Araya G, Sánchez-Ferrer CF, Peiró C. RESOLVIN E1 ATTENUATES DOXORUBICIN-INDUCED ENDOTHELIAL SENESCENCE BY MODULATING NLRP3 INFLAMMASOME ACTIVATION. Biochem Pharmacol 2022;:115078. [PMID: 35551917 DOI: 10.1016/j.bcp.2022.115078] [Reference Citation Analysis]
108 Kim N, Thatcher TH, Sime PJ, Phipps RP. Corticosteroids inhibit anti-IgE activities of specialized proresolving mediators on B cells from asthma patients. JCI Insight 2017;2:e88588. [PMID: 28194434 DOI: 10.1172/jci.insight.88588] [Cited by in Crossref: 8] [Cited by in F6Publishing: 6] [Article Influence: 1.6] [Reference Citation Analysis]
109 Rosenthal MD, Vanzant EL, Moore FA. Chronic Critical Illness and PICS Nutritional Strategies. J Clin Med 2021;10:2294. [PMID: 34070395 DOI: 10.3390/jcm10112294] [Reference Citation Analysis]
110 Hofmann B, Steinhilber D. 5-Lipoxygenase inhibitors: a review of recent patents (2010-2012). Expert Opin Ther Pat 2013;23:895-909. [PMID: 23600432 DOI: 10.1517/13543776.2013.791678] [Cited by in Crossref: 26] [Cited by in F6Publishing: 24] [Article Influence: 2.9] [Reference Citation Analysis]
111 Tateishi N, Kakutani S, Kawashima H, Shibata H, Morita I. Dietary supplementation of arachidonic acid increases arachidonic acid and lipoxin A₄ contents in colon, but does not affect severity or prostaglandin E₂ content in murine colitis model. Lipids Health Dis 2014;13:30. [PMID: 24507383 DOI: 10.1186/1476-511X-13-30] [Cited by in Crossref: 25] [Cited by in F6Publishing: 11] [Article Influence: 3.1] [Reference Citation Analysis]
112 Duri K, Gumbo FZ, Munjoma PT, Chandiwana P, Mhandire K, Ziruma A, Macpherson A, Rusakaniko S, Gomo E, Misselwitz B, Mazengera LR; UZ-CHS Birth Cohort Team. The University of Zimbabwe College of Health Sciences (UZ-CHS) BIRTH COHORT study: rationale, design and methods. BMC Infect Dis 2020;20:725. [PMID: 33008316 DOI: 10.1186/s12879-020-05432-6] [Reference Citation Analysis]
113 Blunder S, Rühl R, Moosbrugger-Martinz V, Krimmel C, Geisler A, Zhu H, Crumrine D, Elias PM, Gruber R, Schmuth M, Dubrac S. Alterations in Epidermal Eicosanoid Metabolism Contribute to Inflammation and Impaired Late Differentiation in FLG-Mutated Atopic Dermatitis. J Invest Dermatol 2017;137:706-15. [PMID: 27793761 DOI: 10.1016/j.jid.2016.09.034] [Cited by in Crossref: 21] [Cited by in F6Publishing: 20] [Article Influence: 3.5] [Reference Citation Analysis]
114 Kordinas V, Ioannidis A, Chatzipanagiotou S. The Telomere/Telomerase System in Chronic Inflammatory Diseases. Cause or Effect? Genes (Basel) 2016;7:E60. [PMID: 27598205 DOI: 10.3390/genes7090060] [Cited by in Crossref: 59] [Cited by in F6Publishing: 61] [Article Influence: 9.8] [Reference Citation Analysis]
115 Liao Z, Dong J, Wu W, Yang T, Wang T, Guo L, Chen L, Xu D, Wen F. Resolvin D1 attenuates inflammation in lipopolysaccharide-induced acute lung injury through a process involving the PPARγ/NF-κB pathway. Respir Res 2012;13:110. [PMID: 23199346 DOI: 10.1186/1465-9921-13-110] [Cited by in Crossref: 101] [Cited by in F6Publishing: 104] [Article Influence: 10.1] [Reference Citation Analysis]
116 Trilleaud C, Gauttier V, Biteau K, Girault I, Belarif L, Mary C, Pengam S, Teppaz G, Thepenier V, Danger R, Robert-Siegwald G, Néel M, Bruneau S, Glémain A, Néel A, Poupon A, Mosnier JF, Chêne G, Dubourdeau M, Blancho G, Vanhove B, Poirier N. Agonist anti-ChemR23 mAb reduces tissue neutrophil accumulation and triggers chronic inflammation resolution. Sci Adv 2021;7:eabd1453. [PMID: 33811066 DOI: 10.1126/sciadv.abd1453] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
117 Bäck M, Yurdagul A Jr, Tabas I, Öörni K, Kovanen PT. Inflammation and its resolution in atherosclerosis: mediators and therapeutic opportunities. Nat Rev Cardiol 2019;16:389-406. [PMID: 30846875 DOI: 10.1038/s41569-019-0169-2] [Cited by in Crossref: 147] [Cited by in F6Publishing: 184] [Article Influence: 73.5] [Reference Citation Analysis]
118 Emre C, Hjorth E, Bharani K, Carroll S, Granholm AC, Schultzberg M. Receptors for pro-resolving mediators are increased in Alzheimer's disease brain. Brain Pathol 2020;30:614-40. [PMID: 31912564 DOI: 10.1111/bpa.12812] [Cited by in Crossref: 17] [Cited by in F6Publishing: 14] [Article Influence: 8.5] [Reference Citation Analysis]
119 Gür ZT, Çalışkan B, Banoglu E. Drug discovery approaches targeting 5-lipoxygenase-activating protein (FLAP) for inhibition of cellular leukotriene biosynthesis. Eur J Med Chem 2018;153:34-48. [PMID: 28784429 DOI: 10.1016/j.ejmech.2017.07.019] [Cited by in Crossref: 21] [Cited by in F6Publishing: 16] [Article Influence: 4.2] [Reference Citation Analysis]
120 Weiss GA, Troxler H, Klinke G, Rogler D, Braegger C, Hersberger M. High levels of anti-inflammatory and pro-resolving lipid mediators lipoxins and resolvins and declining docosahexaenoic acid levels in human milk during the first month of lactation. Lipids Health Dis 2013;12:89. [PMID: 23767972 DOI: 10.1186/1476-511X-12-89] [Cited by in Crossref: 91] [Cited by in F6Publishing: 53] [Article Influence: 10.1] [Reference Citation Analysis]
121 Nordgren TM, Bauer CD, Heires AJ, Poole JA, Wyatt TA, West WW, Romberger DJ. Maresin-1 reduces airway inflammation associated with acute and repetitive exposures to organic dust. Transl Res 2015;166:57-69. [PMID: 25655838 DOI: 10.1016/j.trsl.2015.01.001] [Cited by in Crossref: 19] [Cited by in F6Publishing: 22] [Article Influence: 2.7] [Reference Citation Analysis]
122 Fahmy AM, Hardten DR. Treating ocular surface disease: new agents in development. Clin Ophthalmol 2011;5:465-72. [PMID: 21573093 DOI: 10.2147/OPTH.S12291] [Cited by in Crossref: 1] [Cited by in F6Publishing: 4] [Article Influence: 0.1] [Reference Citation Analysis]
123 Fujieda Y, Manno A, Hayashi Y, Rhodes N, Guo L, Arita M, Bamba T, Fukusaki E. Inflammation and resolution are associated with upregulation of fatty acid β-oxidation in Zymosan-induced peritonitis. PLoS One 2013;8:e66270. [PMID: 23776651 DOI: 10.1371/journal.pone.0066270] [Cited by in Crossref: 27] [Cited by in F6Publishing: 28] [Article Influence: 3.0] [Reference Citation Analysis]
124 Abd-elghafour BA, El-sayed NM, Ahmed AA, Zaitone SA, Moustafa YM. Aspirin and (or) omega-3 polyunsaturated fatty acids protect against corticohippocampal neurodegeneration and downregulate lipoxin A 4 production and formyl peptide receptor-like 1 expression in pentylenetetrazole-kindled rats. Can J Physiol Pharmacol 2017;95:340-8. [DOI: 10.1139/cjpp-2016-0060] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 1.4] [Reference Citation Analysis]
125 Ariel A, Timor O. Hanging in the balance: endogenous anti-inflammatory mechanisms in tissue repair and fibrosis: Endogenous mediators in tissue healing and recovery. J Pathol 2013;229:250-63. [DOI: 10.1002/path.4108] [Cited by in Crossref: 63] [Cited by in F6Publishing: 60] [Article Influence: 6.3] [Reference Citation Analysis]
126 Prieto P, Rosales-Mendoza CE, Terrón V, Toledano V, Cuadrado A, López-Collazo E, Bannenberg G, Martín-Sanz P, Fernández-Velasco M, Boscá L. Activation of autophagy in macrophages by pro-resolving lipid mediators. Autophagy 2015;11:1729-44. [PMID: 26506892 DOI: 10.1080/15548627.2015.1078958] [Cited by in Crossref: 39] [Cited by in F6Publishing: 35] [Article Influence: 6.5] [Reference Citation Analysis]
127 Ariel A, Serhan CN. New Lives Given by Cell Death: Macrophage Differentiation Following Their Encounter with Apoptotic Leukocytes during the Resolution of Inflammation. Front Immunol 2012;3:4. [PMID: 22566890 DOI: 10.3389/fimmu.2012.00004] [Cited by in Crossref: 98] [Cited by in F6Publishing: 110] [Article Influence: 9.8] [Reference Citation Analysis]
128 Rosenthal MD, Vanzant EL, Martindale RG, Moore FA. Evolving paradigms in the nutritional support of critically ill surgical patients. Curr Probl Surg 2015;52:147-82. [PMID: 25946621 DOI: 10.1067/j.cpsurg.2015.02.003] [Cited by in Crossref: 27] [Cited by in F6Publishing: 16] [Article Influence: 3.9] [Reference Citation Analysis]
129 Seelaender M, Batista M Jr, Lira F, Silverio R, Rossi-Fanelli F. Inflammation in cancer cachexia: to resolve or not to resolve (is that the question?). Clin Nutr 2012;31:562-6. [PMID: 22348869 DOI: 10.1016/j.clnu.2012.01.011] [Cited by in Crossref: 30] [Cited by in F6Publishing: 28] [Article Influence: 3.0] [Reference Citation Analysis]
130 Gil A, Gil F. Fish, a Mediterranean source of n-3 PUFA: benefits do not justify limiting consumption. Br J Nutr 2015;113 Suppl 2:S58-67. [PMID: 26148923 DOI: 10.1017/S0007114514003742] [Cited by in Crossref: 65] [Cited by in F6Publishing: 19] [Article Influence: 9.3] [Reference Citation Analysis]
131 García RA, Ito BR, Lupisella JA, Carson NA, Hsu MY, Fernando G, Heroux M, Bouvier M, Dierks E, Kick EK, Gordon DA, Chen J, Mintier G, Carrier M, St-Onge S, Shah H, Towne J, Bucardo MS, Ma X, Ryan CS, Wurtz NR, Ostrowski J, Villarreal FJ. Preservation of Post-Infarction Cardiac Structure and Function via Long-Term Oral Formyl Peptide Receptor Agonist Treatment. JACC Basic Transl Sci 2019;4:905-20. [PMID: 31909300 DOI: 10.1016/j.jacbts.2019.07.005] [Cited by in Crossref: 12] [Cited by in F6Publishing: 11] [Article Influence: 4.0] [Reference Citation Analysis]
132 Livshits G, Kalinkovich A. Receptors for pro-resolving mediators as a therapeutic tool for smooth muscle remodeling-associated disorders. Pharmacol Res 2021;164:105340. [PMID: 33276103 DOI: 10.1016/j.phrs.2020.105340] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
133 Abdelmoaty S, Wigerblad G, Bas DB, Codeluppi S, Fernandez-Zafra T, El-Awady el-S, Moustafa Y, Abdelhamid Ael-D, Brodin E, Svensson CI. Spinal actions of lipoxin A4 and 17(R)-resolvin D1 attenuate inflammation-induced mechanical hypersensitivity and spinal TNF release. PLoS One 2013;8:e75543. [PMID: 24086560 DOI: 10.1371/journal.pone.0075543] [Cited by in Crossref: 51] [Cited by in F6Publishing: 49] [Article Influence: 5.7] [Reference Citation Analysis]
134 Nordgren TM, Anderson Berry A, Van Ormer M, Zoucha S, Elliott E, Johnson R, McGinn E, Cave C, Rilett K, Weishaar K, Maddipati SS, Appeah H, Hanson C. Omega-3 Fatty Acid Supplementation, Pro-Resolving Mediators, and Clinical Outcomes in Maternal-Infant Pairs. Nutrients 2019;11:E98. [PMID: 30621269 DOI: 10.3390/nu11010098] [Cited by in Crossref: 7] [Cited by in F6Publishing: 8] [Article Influence: 2.3] [Reference Citation Analysis]
135 Khophai S, Thanee M, Techasen A, Namwat N, Klanrit P, Titapun A, Jarearnrat A, Sa-Ngiamwibool P, Loilome W. Zileuton suppresses cholangiocarcinoma cell proliferation and migration through inhibition of the Akt signaling pathway. Onco Targets Ther 2018;11:7019-29. [PMID: 30410359 DOI: 10.2147/OTT.S178942] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 1.8] [Reference Citation Analysis]
136 Evans DC, Martindale RG, Kiraly LN, Jones CM. Nutrition optimization prior to surgery. Nutr Clin Pract 2014;29:10-21. [PMID: 24347529 DOI: 10.1177/0884533613517006] [Cited by in Crossref: 79] [Cited by in F6Publishing: 59] [Article Influence: 8.8] [Reference Citation Analysis]
137 Hiram R. Resolution-promoting autacoids demonstrate promising cardioprotective effects against heart diseases. Mol Biol Rep 2022. [PMID: 35142983 DOI: 10.1007/s11033-022-07230-6] [Reference Citation Analysis]
138 Trindade-da-Silva CA, Bettaieb A, Napimoga MH, Lee KSS, Inceoglu B, Ueira-Vieira C, Bruun D, Goswami SK, Haj FG, Hammock BD. Soluble Epoxide Hydrolase Pharmacological Inhibition Decreases Alveolar Bone Loss by Modulating Host Inflammatory Response, RANK-Related Signaling, Endoplasmic Reticulum Stress, and Apoptosis. J Pharmacol Exp Ther 2017;361:408-16. [PMID: 28356494 DOI: 10.1124/jpet.116.238113] [Cited by in Crossref: 12] [Cited by in F6Publishing: 12] [Article Influence: 2.4] [Reference Citation Analysis]
139 Suárez-Lledó A, Leiva-Badosa E, Llop-Talaveron JM, Fernández-Alvarez M, Farran-Teixidor L, Miró-Martín M, Virgili-Casas N, Creus-Costas G, Bas-Minguet J, Poyatos-Canton E, Navarro-Velazquez S, Badia-Tahull MB. Clinical, randomized, double blind clinical trial to study the effect of parenteral supplementation with fish oil emulsion in the nutritional support in esophagectomized patients. Medicine (Baltimore) 2021;100:e26426. [PMID: 34160431 DOI: 10.1097/MD.0000000000026426] [Reference Citation Analysis]
140 Nyirenda CK, Kabagambe EK, Koethe JR, Kiage JN, Chi BH, Musonda P, Blevins M, Bosire CN, Tsai MY, Heimburger DC. Plasma Fatty Acids in Zambian Adults with HIV/AIDS: Relation to Dietary Intake and Cardiovascular Risk Factors. J Nutr Metab 2015;2015:635817. [PMID: 26161268 DOI: 10.1155/2015/635817] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 0.6] [Reference Citation Analysis]
141 Bian Z, Guo Y, Luo Y, Tremblay A, Zhang X, Dharma S, Mishra A, Liu Y. CD47 deficiency does not impede polymorphonuclear neutrophil transmigration but attenuates granulopoiesis at the postacute stage of colitis. J Immunol 2013;190:411-7. [PMID: 23203922 DOI: 10.4049/jimmunol.1201963] [Cited by in Crossref: 15] [Cited by in F6Publishing: 14] [Article Influence: 1.5] [Reference Citation Analysis]
142 Gilbert K, Malick M, Madingou N, Touchette C, Bourque-riel V, Tomaro L, Rousseau G. Metabolites derived from omega-3 polyunsaturated fatty acids are important for cardioprotection. European Journal of Pharmacology 2015;769:147-53. [DOI: 10.1016/j.ejphar.2015.11.010] [Cited by in Crossref: 14] [Cited by in F6Publishing: 14] [Article Influence: 2.0] [Reference Citation Analysis]
143 Mariqueo TA, Zúñiga-Hernández J. Omega-3 derivatives, specialized pro-resolving mediators: Promising therapeutic tools for the treatment of pain in chronic liver disease. Prostaglandins Leukot Essent Fatty Acids 2020;158:102095. [PMID: 32450460 DOI: 10.1016/j.plefa.2020.102095] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 2.5] [Reference Citation Analysis]
144 Rey C, Delpech JC, Madore C, Nadjar A, Greenhalgh AD, Amadieu C, Aubert A, Pallet V, Vaysse C, Layé S, Joffre C. Dietary n-3 long chain PUFA supplementation promotes a pro-resolving oxylipin profile in the brain. Brain Behav Immun 2019;76:17-27. [PMID: 30086401 DOI: 10.1016/j.bbi.2018.07.025] [Cited by in Crossref: 31] [Cited by in F6Publishing: 27] [Article Influence: 7.8] [Reference Citation Analysis]
145 Schulze MB, Minihane AM, Saleh RNM, Risérus U. Intake and metabolism of omega-3 and omega-6 polyunsaturated fatty acids: nutritional implications for cardiometabolic diseases. Lancet Diabetes Endocrinol 2020;8:915-30. [PMID: 32949497 DOI: 10.1016/S2213-8587(20)30148-0] [Cited by in Crossref: 17] [Cited by in F6Publishing: 5] [Article Influence: 8.5] [Reference Citation Analysis]
146 Oliveira Perucci L, Pereira Santos TA, Campi Santos P, Ribeiro Teixeira LC, Nessralla Alpoim P, Braga Gomes K, Pires Sousa L, Sant'Ana Dusse LM, Talvani A. Pre-eclampsia is associated with reduced resolvin D1 and maresin 1 to leukotriene B4 ratios in the plasma. Am J Reprod Immunol 2020;83:e13206. [PMID: 31679164 DOI: 10.1111/aji.13206] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 2.0] [Reference Citation Analysis]
147 Chinthamani S, Odusanwo O, Mondal N, Nelson J, Neelamegham S, Baker OJ. Lipoxin A4 inhibits immune cell binding to salivary epithelium and vascular endothelium. Am J Physiol Cell Physiol 2012;302:C968-78. [PMID: 22205391 DOI: 10.1152/ajpcell.00259.2011] [Cited by in Crossref: 17] [Cited by in F6Publishing: 17] [Article Influence: 1.5] [Reference Citation Analysis]
148 Rosenthal MD, Patel J, Staton K, Martindale RG, Moore FA, Upchurch GR Jr. Can Specialized Pro-resolving Mediators Deliver Benefit Originally Expected from Fish Oil? Curr Gastroenterol Rep 2018;20:40. [PMID: 30078085 DOI: 10.1007/s11894-018-0647-4] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 1.5] [Reference Citation Analysis]
149 Holliday ND, Watson SJ, Brown AJ. Drug discovery opportunities and challenges at g protein coupled receptors for long chain free Fatty acids. Front Endocrinol (Lausanne) 2011;2:112. [PMID: 22649399 DOI: 10.3389/fendo.2011.00112] [Cited by in Crossref: 14] [Cited by in F6Publishing: 28] [Article Influence: 1.4] [Reference Citation Analysis]
150 Cristiano C, Volpicelli F, Crispino M, Lacivita E, Russo R, Leopoldo M, Calignano A, Perrone-capano C. Behavioral, Anti-Inflammatory, and Neuroprotective Effects of a Novel FPR2 Agonist in Two Mouse Models of Autism. Pharmaceuticals 2022;15:161. [DOI: 10.3390/ph15020161] [Reference Citation Analysis]
151 Caligiuri SPB, Parikh M, Stamenkovic A, Pierce GN, Aukema HM. Dietary modulation of oxylipins in cardiovascular disease and aging. Am J Physiol Heart Circ Physiol 2017;313:H903-18. [PMID: 28801523 DOI: 10.1152/ajpheart.00201.2017] [Cited by in Crossref: 42] [Cited by in F6Publishing: 38] [Article Influence: 8.4] [Reference Citation Analysis]
152 Wang X, Zhu M, Hjorth E, Cortés-Toro V, Eyjolfsdottir H, Graff C, Nennesmo I, Palmblad J, Eriksdotter M, Sambamurti K, Fitzgerald JM, Serhan CN, Granholm AC, Schultzberg M. Resolution of inflammation is altered in Alzheimer's disease. Alzheimers Dement 2015;11:40-50.e1-2. [PMID: 24530025 DOI: 10.1016/j.jalz.2013.12.024] [Cited by in Crossref: 144] [Cited by in F6Publishing: 141] [Article Influence: 18.0] [Reference Citation Analysis]
153 Vinolo MA, Rodrigues HG, Nachbar RT, Curi R. Regulation of inflammation by short chain fatty acids. Nutrients. 2011;3:858-876. [PMID: 22254083 DOI: 10.3390/nu3100858] [Cited by in Crossref: 650] [Cited by in F6Publishing: 593] [Article Influence: 59.1] [Reference Citation Analysis]
154 Im DS. Intercellular Lipid Mediators and GPCR Drug Discovery. Biomol Ther (Seoul) 2013;21:411-22. [PMID: 24404331 DOI: 10.4062/biomolther.2013.080] [Cited by in Crossref: 28] [Cited by in F6Publishing: 27] [Article Influence: 3.5] [Reference Citation Analysis]
155 Wang X, Puerta E, Cedazo-Minguez A, Hjorth E, Schultzberg M. Insufficient resolution response in the hippocampus of a senescence-accelerated mouse model--SAMP8. J Mol Neurosci 2015;55:396-405. [PMID: 24913689 DOI: 10.1007/s12031-014-0346-z] [Cited by in Crossref: 17] [Cited by in F6Publishing: 17] [Article Influence: 2.1] [Reference Citation Analysis]
156 Wang RX, Colgan SP. Special pro-resolving mediator (SPM) actions in regulating gastro-intestinal inflammation and gut mucosal immune responses. Mol Aspects Med 2017;58:93-101. [PMID: 28232096 DOI: 10.1016/j.mam.2017.02.002] [Cited by in Crossref: 11] [Cited by in F6Publishing: 10] [Article Influence: 2.2] [Reference Citation Analysis]
157 Stulnig TM. The ZONE Diet and Metabolic Control in Type 2 Diabetes. J Am Coll Nutr 2015;34 Suppl 1:39-41. [PMID: 26400433 DOI: 10.1080/07315724.2015.1080110] [Reference Citation Analysis]
158 Bhatt DL, Hull MA, Song M, Van Hulle C, Carlsson C, Chapman MJ, Toth PP. Beyond cardiovascular medicine: potential future uses of icosapent ethyl. Eur Heart J Suppl 2020;22:J54-64. [PMID: 33061868 DOI: 10.1093/eurheartj/suaa119] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
159 Lands B. Consequences of essential fatty acids. Nutrients 2012;4:1338-57. [PMID: 23112921 DOI: 10.3390/nu4091338] [Cited by in Crossref: 52] [Cited by in F6Publishing: 42] [Article Influence: 5.2] [Reference Citation Analysis]
160 Fenton JI, Hord NG, Ghosh S, Gurzell EA. Immunomodulation by dietary long chain omega-3 fatty acids and the potential for adverse health outcomes. Prostaglandins Leukot Essent Fatty Acids 2013;89:379-90. [PMID: 24183073 DOI: 10.1016/j.plefa.2013.09.011] [Cited by in Crossref: 56] [Cited by in F6Publishing: 55] [Article Influence: 6.2] [Reference Citation Analysis]
161 Calandria JM, Asatryan A, Balaszczuk V, Knott EJ, Jun BK, Mukherjee PK, Belayev L, Bazan NG. NPD1-mediated stereoselective regulation of BIRC3 expression through cREL is decisive for neural cell survival. Cell Death Differ 2015;22:1363-77. [PMID: 25633199 DOI: 10.1038/cdd.2014.233] [Cited by in Crossref: 23] [Cited by in F6Publishing: 24] [Article Influence: 3.3] [Reference Citation Analysis]
162 Markworth JF, Vella L, Lingard BS, Tull DL, Rupasinghe TW, Sinclair AJ, Maddipati KR, Cameron-Smith D. Human inflammatory and resolving lipid mediator responses to resistance exercise and ibuprofen treatment. Am J Physiol Regul Integr Comp Physiol 2013;305:R1281-96. [PMID: 24089379 DOI: 10.1152/ajpregu.00128.2013] [Cited by in Crossref: 91] [Cited by in F6Publishing: 80] [Article Influence: 10.1] [Reference Citation Analysis]
163 Morisseau C, Hammock BD. Impact of soluble epoxide hydrolase and epoxyeicosanoids on human health. Annu Rev Pharmacol Toxicol 2013;53:37-58. [PMID: 23020295 DOI: 10.1146/annurev-pharmtox-011112-140244] [Cited by in Crossref: 301] [Cited by in F6Publishing: 292] [Article Influence: 30.1] [Reference Citation Analysis]
164 Gladine C, Newman JW, Durand T, Pedersen TL, Galano JM, Demougeot C, Berdeaux O, Pujos-Guillot E, Mazur A, Comte B. Lipid profiling following intake of the omega 3 fatty acid DHA identifies the peroxidized metabolites F4-neuroprostanes as the best predictors of atherosclerosis prevention. PLoS One 2014;9:e89393. [PMID: 24558496 DOI: 10.1371/journal.pone.0089393] [Cited by in Crossref: 60] [Cited by in F6Publishing: 56] [Article Influence: 7.5] [Reference Citation Analysis]
165 Salas-Hernández A, Ruz-Cortés F, Bruggendieck F, Espinoza-Perez C, Espitia-Corredor J, Varela NM, Quiñones LA, Sánchez-Ferrer C, Peiró C, Díaz-Araya G. Resolvin D1 reduces expression and secretion of cytokines and monocyte adhesion triggered by Angiotensin II, in rat cardiac fibroblasts. Biomed Pharmacother 2021;141:111947. [PMID: 34328122 DOI: 10.1016/j.biopha.2021.111947] [Reference Citation Analysis]
166 Emre C, Arroyo-García LE, Do KV, Jun B, Ohshima M, Alcalde SG, Cothern ML, Maioli S, Nilsson P, Hjorth E, Fisahn A, Bazan NG, Schultzberg M. Intranasal delivery of pro-resolving lipid mediators rescues memory and gamma oscillation impairment in AppNL-G-F/NL-G-F mice. Commun Biol 2022;5:245. [PMID: 35314851 DOI: 10.1038/s42003-022-03169-3] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
167 Isaak M, Ulu A, Osunde A, Nordgren TM, Hanson C. Nutritional Factors in Occupational Lung Disease. Curr Allergy Asthma Rep 2021;21:24. [PMID: 33768348 DOI: 10.1007/s11882-021-01003-0] [Reference Citation Analysis]
168 Zhuo Y, Zhang S, Li C, Yang L, Gao H, Wang X. Resolvin D1 Promotes SIRT1 Expression to Counteract the Activation of STAT3 and NF-κB in Mice with Septic-Associated Lung Injury. Inflammation 2018;41:1762-71. [PMID: 30014231 DOI: 10.1007/s10753-018-0819-2] [Cited by in Crossref: 15] [Cited by in F6Publishing: 15] [Article Influence: 5.0] [Reference Citation Analysis]
169 Szefel J, Kruszewski WJ, Sobczak E. Factors influencing the eicosanoids synthesis in vivo. Biomed Res Int 2015;2015:690692. [PMID: 25861641 DOI: 10.1155/2015/690692] [Cited by in Crossref: 8] [Cited by in F6Publishing: 7] [Article Influence: 1.1] [Reference Citation Analysis]
170 Hu S, Mao-Ying QL, Wang J, Wang ZF, Mi WL, Wang XW, Jiang JW, Huang YL, Wu GC, Wang YQ. Lipoxins and aspirin-triggered lipoxin alleviate bone cancer pain in association with suppressing expression of spinal proinflammatory cytokines. J Neuroinflammation 2012;9:278. [PMID: 23268791 DOI: 10.1186/1742-2094-9-278] [Cited by in Crossref: 34] [Cited by in F6Publishing: 37] [Article Influence: 3.4] [Reference Citation Analysis]
171 Caligiuri SP, Aukema HM, Ravandi A, Pierce GN. Elevated levels of pro-inflammatory oxylipins in older subjects are normalized by flaxseed consumption. Exp Gerontol 2014;59:51-7. [PMID: 24747581 DOI: 10.1016/j.exger.2014.04.005] [Cited by in Crossref: 45] [Cited by in F6Publishing: 40] [Article Influence: 5.6] [Reference Citation Analysis]
172 Miyazawa K, Fukunaga H, Tatewaki Y, Takano Y, Yamamoto S, Mutoh T, Taki Y. Alzheimer's Disease and Specialized Pro-Resolving Lipid Mediators: Do MaR1, RvD1, and NPD1 Show Promise for Prevention and Treatment? Int J Mol Sci 2020;21:E5783. [PMID: 32806612 DOI: 10.3390/ijms21165783] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 1.5] [Reference Citation Analysis]
173 Woodcock SR, Bonacci G, Gelhaus SL, Schopfer FJ. Nitrated fatty acids: synthesis and measurement. Free Radic Biol Med 2013;59:14-26. [PMID: 23200809 DOI: 10.1016/j.freeradbiomed.2012.11.015] [Cited by in Crossref: 43] [Cited by in F6Publishing: 40] [Article Influence: 4.3] [Reference Citation Analysis]
174 Shryock N, McBerry C, Salazar Gonzalez RM, Janes S, Costa FT, Aliberti J. Lipoxin A₄ and 15-epi-lipoxin A₄ protect against experimental cerebral malaria by inhibiting IL-12/IFN-γ in the brain. PLoS One 2013;8:e61882. [PMID: 23613965 DOI: 10.1371/journal.pone.0061882] [Cited by in Crossref: 22] [Cited by in F6Publishing: 20] [Article Influence: 2.4] [Reference Citation Analysis]
175 Hua J, Jin Y, Chen Y, Inomata T, Lee H, Chauhan SK, Petasis NA, Serhan CN, Dana R. The resolvin D1 analogue controls maturation of dendritic cells and suppresses alloimmunity in corneal transplantation. Invest Ophthalmol Vis Sci 2014;55:5944-51. [PMID: 25146982 DOI: 10.1167/iovs.14-14356] [Cited by in Crossref: 33] [Cited by in F6Publishing: 35] [Article Influence: 4.1] [Reference Citation Analysis]
176 Ponce J, Ulu A, Hanson C, Cameron-smith E, Bertoni J, Wuebker J, Fisher A, Siu K, Marmelat V, Adamec J, Bhatti D. Role of Specialized Pro-resolving Mediators in Reducing Neuroinflammation in Neurodegenerative Disorders. Front Aging Neurosci 2022;14:780811. [DOI: 10.3389/fnagi.2022.780811] [Reference Citation Analysis]
177 Rosenthal MD, Brakenridge S, Rosenthal CM, Moore FA. Nutritional Support in the Setting of Persistent Inflammation, Immunosuppression, and Catabolism Syndrome (PICS). Curr Surg Rep 2016;4. [DOI: 10.1007/s40137-016-0152-3] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
178 Ramon S, Bancos S, Serhan CN, Phipps RP. Lipoxin A₄ modulates adaptive immunity by decreasing memory B-cell responses via an ALX/FPR2-dependent mechanism. Eur J Immunol 2014;44:357-69. [PMID: 24166736 DOI: 10.1002/eji.201343316] [Cited by in Crossref: 48] [Cited by in F6Publishing: 49] [Article Influence: 6.0] [Reference Citation Analysis]
179 Mas E, Croft KD, Zahra P, Barden A, Mori TA. Resolvins D1, D2, and Other Mediators of Self-Limited Resolution of Inflammation in Human Blood following n-3 Fatty Acid Supplementation. Clinical Chemistry 2012;58:1476-84. [DOI: 10.1373/clinchem.2012.190199] [Cited by in Crossref: 180] [Cited by in F6Publishing: 171] [Article Influence: 18.0] [Reference Citation Analysis]